PPT-Pharmaceutical Patents, TRIPS Flexibilities and Access to M

Zimbabwe Presentation t o Civil Society meeting Harare 21 January 2014 Patents make medicines unaffordable Patents create monopolies and dependencies Beneficial for RampD companies in rich countries. tion’s Agreement on Rights, the TRIPS Agreement, which came into effect on 1 January 1995, is the most comprehensive multilateral agreement on •copyright and related rights; •trademar Prof. S K Verma. ISIL, New Delhi. Conference on IP Policy. Bangkok, . December 1, . 2013. Post-TRIPS: new vistas of IP protection. TRIPS Agreement –a most comprehensive multilateral agreement on intellectual property. Zambia. Presentation t. o Civil Society meeting. Lusaka. 1 Oc. tober. . 2013. Patents make medicines unaffordable!. Patents create monopolies and dependencies. Beneficial for R&D companies (in rich countries). TRIPS Flexibilities and . Access to Medicines in . Lesotho – . a public health view. Presentation to Civil Society meeting. Maseru. 12 August 2014. No access to medicines?. Local (clinic) – ordering, staff, calculations, overuse. . and A2M . : Role of BRICS. K M Gopakumar . TWN . International IP Regime . TRIPS and a web of TRIPS Plus ( FTAs) and Bilateral Investment Agreement. TRIPS . is the product of . pharma. and ICT MNC lobbies. LDCs. : . The . Need for Coherence between Patent Law and Public Policies. : . Innovation, Health and Trade. 2. nd. WIPO Inter-Regional Meeting on South-South Cooperation on Patents, Trademarks, Geographical Indications, Industrial Designs and Enforcement. A LEGACY OF LEGISLATION OR LEASE OF THE JUDICIARY? . State of Public Health of India. Hepatitis-B: most common food or water-borne disease in India (National . Center. for Biotechnology Information (. Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . . in . Middle-Income Countries. Othoman. Mellouk. ITPC-MENA. 1st vague of . generic. . competition. . is. . unlikely. to . happen. …. Significant. . increase. in . access. to . treatment. : 14M. Braveen. . Ragunanthan. Keanan. . McGonigle. . Slides prepared . by:. Alison Case, Education and Advocacy Fellow . Katrina . Ciraldo, co-chair, AAN Steering Committee. Any questions/concerns/feedback: . Braveen. . Ragunanthan. Keanan. . McGonigle. . Slides prepared . by:. Alison Case, Education and Advocacy Fellow . Katrina . Ciraldo, co-chair, AAN Steering Committee. Any questions/concerns/feedback: . Global & local pharmaceutical markets. Pharmaceutical industry is one of the largest industries in the world and lies in second place after the . weapons. trade. . The estimated volume of Pharmaceutical sales . Update on Pharmaceutical . Manufacturing Plan for . Africa. Dr. Djoudalbaye Benjamin. Senior Health Officer . African Union Commission. Presentation outline. Definition. TRIPS Agreement. TRIPS and Public Health. for example spent 146 billion on stock buybacks compared to 138 billion on research and development Gilead spent 27 billion on buybacks compared to 17 billion on RD Meanwhile pharmaceutical and heal